Objective: A recent meta-analysis found that DSM-III- and DSM-IV-defined traumas were associated with only slightly higher posttraumatic stress disorder (PTSD) symptoms than nontraumatic stressors. The current study is the first to examine whether DSM-5-defined traumas were associated with higher levels of PTSD than DSM-IV-defined traumas. Further, we examined theoretically relevant event characteristics to determine whether characteristics other than those outlined in the DSM could predict PTSD symptoms. Method: One hundred six women who had experienced a trauma or significant stressor completed questionnaires assessing PTSD, depression, impairment, and event characteristics. Events were rated for whether they qualified as DSM-IV and DSM-5 trauma. Results: There were no significant differences between DSM-IV-defined traumas and stressors. For DSM-5, effect sizes were slightly larger but still nonsignificant (except for significantly higher hyperarousal following traumas vs. stressors). Self-reported fear for one's life significantly predicted PTSD symptoms. Conclusions: Our results indicate that the current DSM-5 definition of trauma, although a slight improvement from DSM-IV, is not highly predictive of who develops PTSD symptoms. Our study also indicates the importance of individual perception of life threat in the prediction of PTSD.

1.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed3. Washington, APA, 1980.
2.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, APA, 1994.
3.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 5. Washington, APA, 2013.
4.
Larsen SE, Pacella ML: Comparing the effects of DSM-congruent traumas vs. DSM-incongruent stressors on PTSD: a meta-analytic review. J Anxiety Disord 2016;38:37-46.
5.
Blanchard EB, Hickling EJ, Mitnick N, Taylor AE, Loos WR, Buckley TC: The impact of severity of physical injury and perception of life threat in the development of post-traumatic stress disorder in motor vehicle accident victims. Behav Res Ther 1995;33:529-534.
6.
Brown GW, Harris T: Social Origins of Depression: a Study of Psychiatric Disorder in Women. New York, Free Press, 1978.
7.
Litz BT, Stein N, Delaney E, Lebowitz L, Nash WP, Silva C, Maguen S: Moral injury and moral repair in war veterans: a preliminary model and intervention strategy. Clin Psychol Rev 2009;29:695-706.
8.
Pinto RJ, Henriques SP, Jongenelen I, Carvalho C, Maia ÂC: The strongest correlates of PTSD for firefighters: number, recency, frequency, or perceived threat of traumatic events? J Trauma Stress 2015;28:434-440.
9.
Leserman J, Barroso J, Pence BW, Salahuddin N, Harmon JL: Trauma, stressful life events, and depression predict HIV-related fatigue. AIDS Care 2008;20:1258-1265.
10.
Weathers FW, Keane TM: The criterion A problem revisited: controversies and challenges in defining and measuring psychological trauma. J Trauma Stress 2007;20:107-121.
11.
Yufik T, Simms LJ: A meta-analytic investigation of the structure of posttraumatic stress disorder symptoms. J Abnorm Psychol 2010;119:764-776.
12.
Watson D, Clark LA: The Mood and Anxiety Symptom Questionnaire. Iowa City, University of Iowa, 1991.
13.
Watson D, Weber K, Assenheimer JS, Clark LA, Strauss ME, McCormick RA: Testing a tripartite model. 1. Evaluating the convergent and discriminant validity of anxiety and depression symptom scales. J Abnorm Psychol 1995;104:3-14.
14.
Mundt JC, Marks IM, Shear K, Greist JM: The Work and Social Adjustment Scale: a simple measure of impairment of functioning. Br J Psychiatry 2002;180:461-464.
15.
Boals A, Schuettler D: A double-edged sword: event centrality, PTSD, and posttraumatic growth. Appl Cogn Psychol 2010;25:817-822.
16.
Rosen GM, Lilienfeld SO: Posttraumatic stress disorder: an empirical investigation of core assumptions. Clin Psychol Rev 2008;28:837-868.
17.
Roberts AL, Dohrenwend BP, Aiello AE, Wright RJ, Maercker A, Galea S, Koenen KC: The stressor criterion for posttraumatic stress disorder: does it matter? J Clin Psychiatry 2012;73:e264-e270.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.